Reactive oxygen species independent cytotoxicity induced by radiocontrast agents in tubular cells (LLC-PK1 and MDCK)

Renal Failure

Volumn 29, Issue 2, 2007, Pages 121-131

  Garofalo, Andrezza Sanches ^a   Borges, Fernanda Teixeira ^a,b   Dalboni, Maria Aparecida ^a   Santos, Oscar Fernando Pavão Dos ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE   (Brazil)

Author keywords

LLC PK1; MDCK; N acetyl cysteine; Radiocontrast agents; Reactive oxygen species

Indexed keywords

ACETYLCYSTEINE; ACRIDINE ORANGE; ALLOPURINOL; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; CIMETIDINE; CITRIC ACID; CONTRAST MEDIUM; DIATRIZOATE; DICHLOROFLUORESCEIN; ETHIDIUM BROMIDE; GLUTATHIONE; HYDROGEN PEROXIDE; IOXAGLIC ACID; LIPOCORTIN 5; MALONALDEHYDE; MEGLUMINE IOXAGLATE PLUS SODIUM IOXAGLATE; PHENOBARBITAL; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; THIOBARBITURIC ACID; UNCLASSIFIED DRUG; UROGRAPHING;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL DAMAGE; CELL DEATH; CELL LINE; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; EXPOSURE; HYPOXIA; KIDNEY TUBULE CELL; NONHUMAN; OSMOLALITY; PRIORITY JOURNAL;

ACETYLCYSTEINE; ANIMALS; ANTIOXIDANTS; CELL HYPOXIA; CELL LINE; CELL LINE, TUMOR; CELL SURVIVAL; CONTRAST MEDIA; DOGS; KIDNEY; L-LACTATE DEHYDROGENASE; LUNG NEOPLASMS; NECROSIS; RADIOISOTOPES; REACTIVE OXYGEN SPECIES; SWINE;

EID: 33847215772     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.1080/08860220601095892     Document Type: Article

References (41)

1. Davidson CJ, Hlatky M, Morris KG, Pieper K, Skelton TN, Schwab SJ, Bashore TM. Cardiovascular and renal toxicity of a nonionic radiographic contrast agent after cardiac catheterization: a prospective trial. Ann Intern Med. 1989;110:119-124.
2. Parfrey PS, Griffiths SM, Barrett BJ, Paul MD, Genge M, Withers J, Farid N, McManamon PJ. Contrast material-induced renal failure to patients with diabetes mellitus, renal insufficiency, or both: a prospective controlled study. N Engl J Med. 1989;320:143-149.
3. Rudnick MR, Berns JS, Cohen RM, Goldfarb S. Contrast media associated nephrotoxicity. Semin Nephrol. 1997;17:15-26.
4. Waybill MM, Waybill PN. Contrast media-induced nephrotoxicity: identification of patients at risk and algorithms for prevention. Vasc Interv Radiol. 2001;12:3-9.
5. Weisberg LS, Kurnik PB, Kurnik BR. Radiocontrast-induced nephropathy in humans: Role of vasoconstriction. Kidney Int. 1992;41:1408-1415.
6. Tumlin JA, Wang A, Murray PT, Mathur VS. Fenoldopam mesylate blocks reductions in renal plasma flow after radiocontrast dye infusion: A pilot trial in the prevention of contrast nephropathy. Am Heart J. 2002;143:894-903.
7. Wasaki M, Sugimoto J, Shirota K. Glucose alters the susceptibility of mesangial cells to contrast media. Invest Radiol. 2001;7:355-362.
8. Katholi RE, Woods WT Jr, Taylor GJ, Deitrick CL, Womack KA, Katholi CR, McCann WP. Oxygen free radicals and contrast nephropathy. Am J Kidney Dis. 1998;32:64-71.
9. Agrawal M, Stouffer GA. Contrast induced nephrotoxicity after angiography. Am Med Sci. 2002;323:252-258.
10. Murphy SW, Barrett BJ, Parfrey PS. Contrast nephropathy. J Am Soc Nephrol. 2000;11:177-182.
11. Solomon R, Werner C, Mann D, D'Elia J, Silva P. Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents. N Engl J Med. 1994;331:1416-1420.
12. Trivedi HS, Moore H, Nasr S, Aggarwal K, Agrawal A, Goel P, Hewett J. A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron Clin Pract. 2003;93:C29-C34.
13. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med. 2000;343:180-184.
14. Drager LF, Andrade L, Barros de Toledo JF, Laurindo FR, Machado Cesar LA, Seguro AC. Renal effects of N-acetyl-cysteine in patients at risk for contrast nephropathy: decrease in oxidant stress-mediated renal tubular injury. Nephrol Dial Transplant. 2004;19:1803-1807.
15. Hull RN, Cherry WR, Weaver GW. The origin and characteristics of a pig kidney cell strain, LLC-PK1. In Vitro. 1976;12:670.
16. American Type Culture Collection. In: Hay R, Mary M, Chen TR, McClintock P, Reid Y, eds. Catalogue of Cell Lines and Hybridomas. 7th ed. Rockville, Md.: ATCC Press, 1992:21.
17. Peuchant E, Delmas-Beauvieux MC, Duborg L, Thomas MJ, Peeromat A, Aparicio M, Clerc M, Combe C. Antioxidant effects of a supplemented very low protein diet in chronic renal failure. Free Radic Biol Med. 1997;22:131-320.
18. Rhoden E, Teloken C, Lucas M, Rhoden C, Mauri M, Zettler C, Bello-Klein A, Barros E. Protective effect of allopurinol in the renal ischemia-reperfusion in uninephrectomized rats. Gen Pharmacol. 2000;35:189-193.
19. Byer K, Khan SR. Citrate provides protection against oxalate and calcium oxalate crystal induced oxidative damage to renal epithelium. J Urol. 2005;173:640-646.
20. Dinu D, Nechifor MT, Movileanu L. Ethanol-induced alterations of the antioxidant defense system in rat kidney. J Biochem Mol Toxicol. 2005;19:386-395.
21. Yang CC, Hsu SP, Wu MS, Chien CT. Effects of vitamin C infusion and vitamin E-coated membrane on hemodialysis-induced oxidative stress. Kidney Int. 2006;69:706-714.
22. Zimmerhackl LB, Mesa H, Kraemer F, Koelmel C, Wiegele G, Brandis M. Tubular toxicity of cyclosporine A and the influence of endothelin-1 in renal cell culture model (LLC-PK1 and MDCK). Pediatr Nephrol. 1997;11:778-783.
23. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis - flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labeled Annexin V. J Immunol Methods. 1995;184:39-51.
24. Ubezio P, Civoli F. Flow cytometric detection of hydrogen peroxide production induced by doxorubicin in cancer cells. Free Radic Biol Med. 1994;16:509-516.
25. Hart MC, Tolson JK, Blocks ER. Supplemental fatty acids alter lipid peroxidation and oxidant injury in endothelial cells. Am J Physiol. 1991;260:L481-L488.
26. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
27. Beaufils H, Idee JM, Berthommier C, Balut C, Bourbouze R, Nimier K, Chicandre-Jouanneau C, Bonnemain B. Iobitridol, a new nonionic low-osmolality contrast agent, and iohexol: impact on renal histology in the rat. Invest Radiol. 1995;30:33-39.
28. Zager RA, Johnson ACM, Hanson SY. Radiographic contrast media-induced tubular injury: Evaluation of oxidant stress and plasma membrane integrity. Kidney Int. 2003;64:128-139.
29. Hizoh I, Haller C. Radiocontrast-induced renal tubular cell apoptosis: hypertonic versus oxidative stress. Invest. Radiol. 2002;37:428-434.
30. Sheridan AM, Schwartz JH, Kroshian VM, Tercyak AM, Laraia J, Masino S, Lieberthal W. Renal mouse proximal tubular cells are more susceptible than MDCK cells to chemical anoxia. Am. J. Physiol. 1993;265:F342-F350.
31. Fanning NF, Manning BJ, Buckley J, Redmond HP. Iodinated contrast media induces neutrophil apoptosis through a mitochondrial and caspase mediated pathway. Br J Radiol. 2002;75:861-873.
32. Hardiek K, Katholi RE, Ramkumar V, Dietrick C. Proximal tubule cell response to radiographic contrast media. Am J Physiol Renal Physiol. 2001;280:F61-F70.
33. Schick SC, Haller C. Comparative cytotoxicity of ionic and non-ionic radiocontrast agents on MDCK cell monolayers in vitro. Nephrol Dial Transplant. 1999;14:342-347.
34. Qanungo S, Wang M, Nieminen AL. N-Acetyl-L-cysteine enhances apoptosis through inhibition of nuclear factor-kappaB in hypoxic murine embryonic fibroblasts. J Biol Chem. 2004;279:50455-50464.
35. Holt S, Goodier D, Marley R, Patch D, Burroughs A, Fernando B, Harry D, Moore K. Improvement in renal function in hepatorenal syndrome with N-acetylcysteine. Lancet. 1999;353:294-295.
36. Morley N, Curnow A, Salter L, Campbell S, Gould D. N-acetyl-L-cysteine prevents DNA damage induced by UVA, UVB and visible radiation in human fibroblasts. J. Photochem. Photobiol. B. 2003;72:55-60.
37. Ricardo KF, Shishido SM, de Oliveira MG, Krieger MH. Characterization of the effect of S-nitroso-N-acetylcysteine in normotensive and hypertensive conscious rats. Nitric Oxide. 2002;7:57-66.
38. Briguori C, Manganelli F, Scarpato P, Elia PP, Golia B, Riviezzo G, Lepore S, Librera M, Villari B, Colombo A, Ricciardelli B. Acetylcysteine and contrast agent-associated nephrotoxicity. J. Am. Coll. Cardiol. 2002;40:298-303.
39. Allaqaband S, Tumuluri R, Malik AM, Gupta A, Volkert P, Shalev Y, Bajwa TK. Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy. Catheter Cardiovasc. Interv. 2002;57:279-283.
40. Durham JD, Caputo C, Dokko J, Zaharakis T, Pahlavan M, Keltz J, Dutka P, Marzo K, Maesaka JK, Fishbane S. A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography. Kidney Int. 2002;62:2202-2207.
41. Gomes VO, Poli de Figueredo CE, Caramori P, Lasevitch R, Bodanese LC, Araujo A, Roedel AP, Caramori AP, Brito FS Jr, Bezerra HG, Nery P, Brizolara A. N-acetylcysteine does not prevent contrast induced nephropathy after cardiac catheterization with an ionic low osmolality contrast medium: a multicentre clinical trial. Heart 2005;91:774-778.